166 related articles for article (PubMed ID: 33624332)
1. Biochemical Investigation of the Interaction of pICln, RioK1 and COPR5 with the PRMT5-MEP50 Complex.
Krzyzanowski A; Gasper R; Adihou H; Hart P'; Waldmann H
Chembiochem; 2021 Jun; 22(11):1908-1914. PubMed ID: 33624332
[TBL] [Abstract][Full Text] [Related]
2. RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity.
Guderian G; Peter C; Wiesner J; Sickmann A; Schulze-Osthoff K; Fischer U; Grimmler M
J Biol Chem; 2011 Jan; 286(3):1976-86. PubMed ID: 21081503
[TBL] [Abstract][Full Text] [Related]
3. Development of Macrocyclic PRMT5-Adaptor Protein Interaction Inhibitors.
Krzyzanowski A; Esser LM; Willaume A; Prudent R; Peter C; 't Hart P; Waldmann H
J Med Chem; 2022 Nov; 65(22):15300-15311. PubMed ID: 36378254
[TBL] [Abstract][Full Text] [Related]
4. The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond.
Stopa N; Krebs JE; Shechter D
Cell Mol Life Sci; 2015 Jun; 72(11):2041-59. PubMed ID: 25662273
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for substrate recruitment to the PRMT5 methylosome.
Mulvaney KM; Blomquist C; Acharya N; Li R; Ranaghan MJ; O'Keefe M; Rodriguez DJ; Young MJ; Kesar D; Pal D; Stokes M; Nelson AJ; Jain SS; Yang A; Mullin-Bernstein Z; Columbus J; Bozal FK; Skepner A; Raymond D; LaRussa S; McKinney DC; Freyzon Y; Baidi Y; Porter D; Aguirre AJ; Ianari A; McMillan B; Sellers WR
Mol Cell; 2021 Sep; 81(17):3481-3495.e7. PubMed ID: 34358446
[TBL] [Abstract][Full Text] [Related]
6. Histone H2A and H4 N-terminal tails are positioned by the MEP50 WD repeat protein for efficient methylation by the PRMT5 arginine methyltransferase.
Burgos ES; Wilczek C; Onikubo T; Bonanno JB; Jansong J; Reimer U; Shechter D
J Biol Chem; 2015 Apr; 290(15):9674-89. PubMed ID: 25713080
[TBL] [Abstract][Full Text] [Related]
7. NF90/NFAR (nuclear factors associated with dsRNA) - a new methylation substrate of the PRMT5-WD45-RioK1 complex.
Cox J; Esser LM; Jüdt M; Schmitz K; Reiffert K; Grimmler M; Stork B; Wesselborg S; Peter C
Biol Chem; 2022 Sep; 403(10):907-915. PubMed ID: 36040368
[TBL] [Abstract][Full Text] [Related]
8. Discovery and Biological Characterization of PRMT5:MEP50 Protein-Protein Interaction Inhibitors.
Asberry AM; Cai X; Deng X; Santiago U; Liu S; Sims HS; Liang W; Xu X; Wan J; Jiang W; Camacho CJ; Dai M; Hu CD
J Med Chem; 2022 Oct; 65(20):13793-13812. PubMed ID: 36206451
[TBL] [Abstract][Full Text] [Related]
9. The Structure and Function of the PRMT5:MEP50 Complex.
Antonysamy S
Subcell Biochem; 2017; 83():185-194. PubMed ID: 28271477
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a First-in-Class Inhibitor of the PRMT5-Substrate Adaptor Interaction.
McKinney DC; McMillan BJ; Ranaghan MJ; Moroco JA; Brousseau M; Mullin-Bernstein Z; O'Keefe M; McCarren P; Mesleh MF; Mulvaney KM; Robinson F; Singh R; Bajrami B; Wagner FF; Hilgraf R; Drysdale MJ; Campbell AJ; Skepner A; Timm DE; Porter D; Kaushik VK; Sellers WR; Ianari A
J Med Chem; 2021 Aug; 64(15):11148-11168. PubMed ID: 34342224
[TBL] [Abstract][Full Text] [Related]
11. Protein arginine methyltransferase 5 catalyzes substrate dimethylation in a distributive fashion.
Wang M; Fuhrmann J; Thompson PR
Biochemistry; 2014 Dec; 53(50):7884-92. PubMed ID: 25485739
[TBL] [Abstract][Full Text] [Related]
12. MEP50/PRMT5 Reduces Gene Expression by Histone Arginine Methylation and this Is Reversed by PKCδ/p38δ Signaling.
Saha K; Adhikary G; Eckert RL
J Invest Dermatol; 2016 Jan; 136(1):214-224. PubMed ID: 26763441
[TBL] [Abstract][Full Text] [Related]
13. Taming PRMT5-adaptor protein interactions.
Sims HS; Dai M
Trends Pharmacol Sci; 2023 Mar; 44(3):134-136. PubMed ID: 36669975
[TBL] [Abstract][Full Text] [Related]
14. Methylosome Protein 50 and PKCδ/p38δ Protein Signaling Control Keratinocyte Proliferation via Opposing Effects on p21Cip1 Gene Expression.
Saha K; Eckert RL
J Biol Chem; 2015 May; 290(21):13521-30. PubMed ID: 25851901
[TBL] [Abstract][Full Text] [Related]
15. MEP50/PRMT5-mediated methylation activates GLI1 in Hedgehog signalling through inhibition of ubiquitination by the ITCH/NUMB complex.
Abe Y; Suzuki Y; Kawamura K; Tanaka N
Commun Biol; 2019; 2():23. PubMed ID: 30675521
[TBL] [Abstract][Full Text] [Related]
16. LKB1 regulates PRMT5 activity in breast cancer.
Lattouf H; Kassem L; Jacquemetton J; Choucair A; Poulard C; Trédan O; Corbo L; Diab-Assaf M; Hussein N; Treilleux I; Le Romancer M
Int J Cancer; 2019 Feb; 144(3):595-606. PubMed ID: 30289978
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2
Ichikawa T; Suekane A; Nakahata S; Iha H; Shimoda K; Murakami T; Morishita K
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474089
[TBL] [Abstract][Full Text] [Related]
18. Sulforaphane inhibits PRMT5 and MEP50 function to suppress the mesothelioma cancer cell phenotype.
Ezeka G; Adhikary G; Kandasamy S; Friedberg JS; Eckert RL
Mol Carcinog; 2021 Jul; 60(7):429-439. PubMed ID: 33872411
[TBL] [Abstract][Full Text] [Related]
19. Glutathionylation Decreases Methyltransferase Activity of PRMT5 and Inhibits Cell Proliferation.
Yi M; Ma Y; Chen Y; Liu C; Wang Q; Deng H
Mol Cell Proteomics; 2020 Nov; 19(11):1910-1920. PubMed ID: 32868396
[TBL] [Abstract][Full Text] [Related]
20. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
Chen H; Lorton B; Gupta V; Shechter D
Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
